PubMed:25163405 / 0-668 JSONTXT

{"project":"PubMed_Structured_Abstracts","denotations":[{"id":"T1","span":{"begin":145,"end":293},"obj":"BACKGROUND"},{"id":"T2","span":{"begin":305,"end":571},"obj":"OBJECTIVE"}],"text":"Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.\nBACKGROUND: Epinastine hydrochloride is a selective histamine H1 receptor antagonist that also inhibits IgE receptor-mediated histamine release from mast cells.\nOBJECTIVE: To show the superiority of epinastine 0.05% ophthalmic solution (epinastine) to placebo ophthalmic solution (placebo) and noninferiority to olopatadine 0.1% ophthalmic solution (olopatadine) for cedar pollen antigen-induced ocular itching and conjunctival hyperemia.\nMETHODS: The study was conducted in ophthalmologically asymptomatic adult volunteers with season"}

{"project":"maxiaofeng52_800_3","denotations":[{"id":"T2","span":{"begin":69,"end":83},"obj":"DP"},{"id":"T5","span":{"begin":145,"end":169},"obj":"CI"},{"id":"T6","span":{"begin":12,"end":36},"obj":"CI"},{"id":"T7","span":{"begin":332,"end":342},"obj":"CI"},{"id":"T9","span":{"begin":370,"end":380},"obj":"CI"},{"id":"T14","span":{"begin":385,"end":392},"obj":"CI"},{"id":"T15","span":{"begin":414,"end":421},"obj":"CI"},{"id":"T19","span":{"begin":445,"end":456},"obj":"CI"},{"id":"T20","span":{"begin":483,"end":494},"obj":"CI"}],"text":"Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.\nBACKGROUND: Epinastine hydrochloride is a selective histamine H1 receptor antagonist that also inhibits IgE receptor-mediated histamine release from mast cells.\nOBJECTIVE: To show the superiority of epinastine 0.05% ophthalmic solution (epinastine) to placebo ophthalmic solution (placebo) and noninferiority to olopatadine 0.1% ophthalmic solution (olopatadine) for cedar pollen antigen-induced ocular itching and conjunctival hyperemia.\nMETHODS: The study was conducted in ophthalmologically asymptomatic adult volunteers with season"}

{"project":"wangzhuo19_800_3","denotations":[{"id":"T12","span":{"begin":370,"end":380},"obj":"CI"},{"id":"T13","span":{"begin":12,"end":36},"obj":"CI"},{"id":"T14","span":{"begin":332,"end":342},"obj":"CI"},{"id":"T19","span":{"begin":145,"end":169},"obj":"CI"},{"id":"T7","span":{"begin":385,"end":392},"obj":"CI"},{"id":"T8","span":{"begin":414,"end":421},"obj":"CI"},{"id":"T21","span":{"begin":69,"end":83},"obj":"DP"},{"id":"T25","span":{"begin":445,"end":456},"obj":"CI"},{"id":"T26","span":{"begin":483,"end":494},"obj":"CI"}],"text":"Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.\nBACKGROUND: Epinastine hydrochloride is a selective histamine H1 receptor antagonist that also inhibits IgE receptor-mediated histamine release from mast cells.\nOBJECTIVE: To show the superiority of epinastine 0.05% ophthalmic solution (epinastine) to placebo ophthalmic solution (placebo) and noninferiority to olopatadine 0.1% ophthalmic solution (olopatadine) for cedar pollen antigen-induced ocular itching and conjunctival hyperemia.\nMETHODS: The study was conducted in ophthalmologically asymptomatic adult volunteers with season"}